Everolimus is an active pharmaceutical ingredient used as an immunosuppressive agent. It is a macrocyclic compound with multiple hydroxyl and ether groups, characterized by a complex stereochemical structure.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 159351-69-6
Sirolimus
pharmaceutical raw material
Sirolimus Impurity 2
Pharmaceutical impurity reference standard
Temsirolimus
pharmaceutical raw material
4-{[(2-Amino-3,5-dibromophenyl)methyl]amino}cyclohexan-1-ol--hydrogen chloride (1/1)
pharmaceutical raw material
Enfuvirtide
pharmaceutical raw material
Tesirin
pharmaceutical raw material
Ibutamoren mesylate
pharmaceutical raw material
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
HKVAMNSJSFKALM-GKUWKFKPSA-N
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC